Molecular medicine is transforming everyday clinical practice from an empirical art to a rational ortho-molecular science. The prevailing concept in this emerging framework of molecular medicine is a personalized approach to disease prevention, diagnosis, prognosis, and treatment. In this mini-review, we discuss the educational and social-ethical issues raised by the advances of biomedical research as related to medical practice; outline the implications of molecular medicine for patients, physicians, and researchers; and underline the responsibilities of academia and the pharmaceutical industry to translate the scientific knowledge to a meaningful improvement of the quality of life across all members of society.
This is a preview of subscription content, log in to check access.
Papavassiliou AG. (2001) Clinical practice in the new era. A fusion of molecular biology and classical medicine is transforming the way we look at and treat diseases. EMBO Rep. 2:80–2.CrossRefGoogle Scholar
Link E, et al. (2008) SLCO1B1 variants and statin-induced myopathy—a genomewide study. N. Engl. J. Med. 359:789–99.CrossRefGoogle Scholar
Kaelin WG, Jr. (2005) The concept of synthetic lethality in the context of anticancer therapy. Nat. Rev. Cancer 5:689–98.PubMedGoogle Scholar
Sharma SV, Bell DW, Settleman J, Haber DA. (2007) Epidermal growth factor receptor mutations in lung cancer. Nat. Rev. Cancer 7:169–81.CrossRefGoogle Scholar
Quackenbush J. (2006) Microarray analysis and tumor classification. N. Engl. J. Med. 354:2463–72.CrossRefGoogle Scholar
Paik S, et al. (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N. Engl. J. Med. 351:2817–26.CrossRefGoogle Scholar
Konstantinopoulos PA, Spentzos D, Cannistra SA. (2008) Gene-expression profiling in epithelial ovarian cancer. Nat. Clin. Pract. Oncol. 5:577–87.CrossRefGoogle Scholar
Jones S, et al. (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321:1801–6.CrossRefGoogle Scholar
Parsons DW, et al. (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807–12.CrossRefGoogle Scholar
Whitney SN, et al. (2008) Principal investigator views of the IRB system. Int. J. Med. Sci. 5:68–72.Google Scholar
Breckenridge A, et al. (2004) Pharmacogenetics: ethical problems and solutions. Nat. Rev. Genet. 5:676–80.Google Scholar
Nathan D, Benz EJ. (2001) Comprehensive cancer centres and the war on cancer. Nat. Rev. Cancer 1:240–5.CrossRefGoogle Scholar